Searchable Alterations Database
Comparison populations are quoted as reported in the source literature (e.g. healthy controls, disease-matched patients).
| Marker / Test | Direction | Category | vs. Comparison | Clinical Context | Key Reference |
|---|
Serologic, cerebrospinal fluid, molecular, and inflammatory biomarkers in Borrelia burgdorferi infection — from early localized disease through disseminated, neuroborreliosis, and post-treatment persistent symptom phenotypes.
Biomarkers below are included only where peer-reviewed literature explicitly reports the marker's direction in Lyme Disease patients relative to a named comparison population — not inferred.
Comparison populations are quoted as reported in the source literature (e.g. healthy controls, disease-matched patients).
| Marker / Test | Direction | Category | vs. Comparison | Clinical Context | Key Reference |
|---|